Clinical Trial News Archive - April 2023
April 3, 2023
- Extremely Rare Gene Variants Point to a Potential Cause of Age-Related Macular Degeneration
- Vico Therapeutics Announces First Patient Dosed in Phase 1/2a Clinical Trial of VO659 in Huntington's Disease and Spinocerebellar Ataxia Types 1 and 3
April 4, 2023
- New shape-shifting antibiotics could fight deadly infections
- Therapy for Rare Bone Disorder Shows Promise in NIH Clinical Trial
- NIH Study Finds That Immunotherapy Substantially Increases Survival of People with Lymphomatoid Granulomatosis
- Biosion Initiates Phase II Clinical Trial of BSI-045B in Atopic Dermatitis
- InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients
- Shionogi Receives U.S. FDA Fast Track Designation for Ensitrelvir Fumaric Acid, an Investigational Oral Antiviral for COVID-19
April 5, 2023
- Clinical study shows Matrikynes significantly improves the structure, function, and appearance of skin
- Biosion Initiates Phase II Clinical Trial of BSI-045B in Atopic Dermatitis
- MAPS PBC Announces Positive Topline Results from Long-Term Observational Follow-Up Study on MDMA-Assisted Therapy for Treatment of PTSD
April 6, 2023
- FDA Commissioner and Chief Scientist Announce Decision to Withdraw Approval of Makena
- Update on Imbruvica (ibrutinib) U.S. Accelerated Approvals for Mantle Cell Lymphoma and Marginal Zone Lymphoma Indications
April 7, 2023
- First Patient Dosed in ENHANCE - China Phase III Trial for Chronic Obstructive Pulmonary Disease
- NIH-Funded Study Finds Doxycycline Reduces Sexually Transmitted Infections by Two-Thirds
April 8, 2023
April 11, 2023
- Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds
- ACELYRIN, INC. Announces Magnitude of Clinical Responses with Izokibep in Psoriatic Arthritis Continues to Improve with Longer Duration of Therapy
April 12, 2023
- ESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancer
- Novaliq Announces Publication of Second Pivotal Phase 3 Trial Data on CyclASol® 0.1% (Cyclosporine Ophthalmic Solution) in JAMA Ophthalmology
April 13, 2023
- Tranexamic Acid Does Not Appear to Prevent Maternal Hemorrhage After Cesarean Delivery
- NaxSwab OTC novel naloxone nasal swab successfully administered by children and adults to potentially rescue someone from an opioid overdose in study
April 14, 2023
- Results from Astellas' Phase 3 SPOTLIGHT Trial of Investigational Zolbetuximab Published in The Lancet
- Soligenix Provides Regulatory Update on HyBryte
April 15, 2023
April 17, 2023
- BioLineRx Announces Publication in Nature Medicine of its GENESIS Phase 3 Clinical Trial Data Evaluating Motixafortide and G-CSF in Stem Cell Mobilization for Autologous Transplantation in Multiple Myeloma
- Sulbactam-Durlobactam Unanimously Recommended for Approval by FDA Advisory Committee
- Agenus Receives Fast Track Designation for Botensilimab and Balstilimab in Colorectal Cancer
- Adding New Vaccine Type to Leading Immunotherapy Dramatically Reduced Melanoma Recurrence
April 18, 2023
- Technoderma Medicines Initiates TDM-105795 Androgenetic Alopecia Phase 2 Clinical Trial
- School Prevalence of Stimulant Therapy for ADHD Associated with Higher Rates of Prescription Stimulant Misuse Among Teens
April 19, 2023
April 20, 2023
April 21, 2023
April 24, 2023
- Drug Combination Restores Ability of Leading Treatment to Signal for Death of Blood Cancer Cells
- NEURO-TTRansform Phase III Results Presented at AAN Showed Eplontersen Demonstrated Consistent and Sustained Improvement in all Measures of Disease and Quality of Life Through 66 Weeks
April 25, 2023
- Atea Pharmaceuticals Announces U.S. FDA Fast Track Designation Granted to Bemnifosbuvir, an Investigational Oral Antiviral, for the Treatment of COVID-19
- NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
- National Multicenter Trial Opens to Study ImmunityBio’s Tri-Ad5 Cancer Vaccines Plus N-803 to Prevent Cancer in People with Lynch Syndrome
- New Vabysmo Data Suggest Greater Retinal Drying Versus Aflibercept in Wet Age-Related Macular Degeneration and Diabetic Macular Edema
April 26, 2023
- Avenge Bio Announces Successful Completion of First Dose Level Cohort in Phase 1/2 Clinical Trial of AVB-001 for the Treatment of Ovarian Cancer
- Regeneron and Alnylam Report Positive Interim Phase 1 Clinical Data on ALN-APP, an Investigational RNAi Therapeutic for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
- Novartis Phase III APPOINT-PNH Trial Shows Investigational Oral Monotherapy Iptacopan Improves Hemoglobin to Near-Normal Levels, Leading to Transfusion Independence in all Treatment-Naïve PNH Patients
April 27, 2023
- Lilly's Tirzepatide Achieved up to 15.7% Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes in SURMOUNT-2
- New Enterade Clinical Study Demonstrates Fewer Stopped Treatments and Lower GI Side Effects for Cancer Patients
April 30, 2023
Clinical trial results archive
- 2024
- January, February, March, April, May, June, July, August, September, October, November
- 2023
- January, February, March, April, May, June, July, August, September, October, November, December
- 2022
- January, February, March, April, May, June, July, August, September, October, November, December
- 2021
- January, February, March, April, May, June, July, August, September, October, November, December
- 2020
- January, February, March, April, May, June, July, August, September, October, November, December
- 2019
- January, February, March, April, May, June, July, August, September, October, November, December
- 2018
- January, February, March, April, May, June, July, August, September, October, November, December
- 2017
- May, June, July, August, September, October, November, December
- 2016
- October
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.